Main Article Content
Thyroid cancer is a relatively rare disease, accounting for about 1% of all new cancer cases each year. However, it is the most common neoplasm of the endocrine system, and its incidence has been increasing over the past few decades. The reasons for this are not entirely clear, but are partly due to improvements in diagnostic methods that allow for early diagnosis. Thyroid cancers usually have a very good long-term prognosis, but nevertheless, about 20% of patients fail due to local or distant tumor recurrence, inability to absorb radioactive iodine, or, in rare cases, progression of well-differentiated tumors to poorly differentiated or undifferentiated. carcinomas. In this article, we would like to highlight the main provisions of the modern approach to the introduction of patients with thyroid cancer.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.